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The specific molecular determinants that govern progenitor expansion and final compartment size in the
myogenic lineage, either during gestation or during regenerative myogenesis, remain largely obscure. Recently,
we retrieved d-asb11 from a zebrafish screen designed to identify gene products that are downregulated during
embryogenesis upon terminal differentiation and identified it as a potential regulator of compartment size in the
ectodermal lineage. A role in mesodermal derivatives remained, however, unexplored. Here we report pan-
vertebrate expression of Asb11 in muscle compartments, where it highly specifically localizes to the Pax7 +
muscle satellite cell compartment. Forced expression of d-asb11 impaired terminal differentiation and caused
enhanced proliferation in the myogenic progenitor compartment both in in vivo and in vitro model systems.
Conversely, introduction of a germline hypomorphic mutation in the zebrafish d-asb11 gene produced prema-
ture differentiation of the muscle progenitors and delayed regenerative responses in adult injured muscle. Thus,
the expression of d-asb11 is necessary for muscle progenitor expansion, whereas its downregulation marks the
onset of terminal differentiation. Hence, we provide evidence that d-asb11 is a principal regulator of embryonic
as well as adult regenerative myogenesis.
Introduction
The establishment of the relative sizes of the variouscompartments in the vertebrate body is one of the most
important and defining processes of developmental biology.
During embryonic development, tissue-specific progenitor
compartments must undergo massive cell expansion to
generate enough volume to produce functionally differen-
tiated tissues. The increase and diversification of vertebrate
compartments played a crucial factor in the terms of evolu-
tion and enabled organisms to cope with different environ-
mental conditions [1–3]. Further, aberrant compartment
regulation is implicated in many serious pathologies (eg,
cancer) [4]. The factors that determine and regulate cell
proliferation and differentiation, thus, defining compart-
ment size and function, remain poorly understood and elu-
cidation of the underlying molecular mechanisms driving
expansion of progenitor compartments represents an im-
portant scientific question.
Likewise, little is known with respect to biological events
triggering muscle compartment expansion [5–7]. In verte-
brates the skeletal muscle arises from an embryonic com-
partment called myotome, originating from a transient
epithelial structure, the dermomyotome, which in turn is
derived from somites. Somites are formed sequentially, as
paired segments of the paraxial mesoderm on either side of
the neural tube, from anterior to posterior, at regular time
intervals. The somites are transient structures patterned by
signals from the surrounding tissue into compartments that
later differentiate into different types of tissues that will
give rise to several trunk structures: sclerotome (precursor
of the bones, cartilages, and tendons), myotome (precursor
of the muscle), and dermatome (precursor of the dermis)
[8–10].
The primary myotome is formed as the first differentiated
muscle from the dermomyotome between E11.5 and E15.5 in
the mouse. There, some myoblasts irreversibly exit the cell
cycle, align with each other, and fuse, forming multinucle-
ated myotubes. After primary myogenesis, secondary myo-
blasts in the dermomyotome use the primary myotome as a
scaffold to attach to and fuse with each other, giving rise to
secondary myotubes. A similar molecular process of myo-
genesis occurs postnatally, to recruit adult muscle precursors
into new myofibers during skeletal muscle damage [11].
Enhanced knowledge of the molecular determinants in the
formation of muscular tissue, both in embryos and adult
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organisms, will help to elucidate important processes in-
volved in developmental biology and give a better under-
standing of degenerative diseases, such as muscular
dystrophy, as well as the process of repair, reproduction, or
replacement of lost or injured cells, possibly leading to new
ways of treatment.
Earlier we reported on efforts to discover the elements
involved in progenitor compartment size regulation by iso-
lating genes that are specifically repressed during terminal
differentiation and thus may be responsible for the prolifer-
ation and expansion of the stem cell compartment [12]. To
this end, mRNA from zebrafish embryos treated with 0.5 mM
all-trans retinoic acid (which terminates progenitor expan-
sion and induces full terminal differentiation) was isolated
and compared with untreated embryos. Differentially ex-
pressed mRNA fragments were tested using whole mount in
situ hybridization (WISH) at different developmental stages.
Finally, 1 fragment was singled out for detailed character-
ization based on its restricted spatiotemporal expression
pattern during late gastrulation and early somitogenesis. The
full-length sequence of the downregulated fragment revealed
that the gene is homologous to the mammalian ankyrin
repeat and suppressor of cytokine signaling (SOCS) box-
containing protein 11 (Asb11). The amino acid sequence of
zebrafish Asb11 has 293 residues, composed of a series of 6
ankyrin repeats at the N-terminus, and a C-terminal SOCS
box domain [12].
The Asb family constitutes a (hemi)chordate-unique gene
family whose members are characterized by variable
numbers of N-terminal ankyrin repeats and a C-terminal
SOCS box [13]. ASB proteins act as substrate receptor
subunits of E3 ligases, enzymes that mediate ubiquitylation
and degradation of target proteins [14–16] and ubiquitin
ligases regulate a plethora of physiologically important
processes [17,18]. Although the zebrafish Asb11 has the
most functional homology with human ASB11, sequence
analysis also showed high homology of zebrafish Asb11
with other mammalian members of the ASB family, most
markedly with ASB9. Considering the fact that mouse and
human Asb9 and Asb11 are also located close to each other
on the genome (which seems to have arisen as the result of a
recent gene duplication event), we proposed that these
genes are both mammalian homologues of zebrafish asb11
[12]. Further, ASB proteins show very high pan-chordate
conservation, Homo sapiens ASB11 and its orthologue in the
urochordate Ciona intestinalis sharing 50% overall similarity
on an amino acid basis, which points to very fundamental
functions in chordate physiology.
Consistently, forced expression of Asb11 in the presump-
tive nervous system of zebrafish embryos maintained cell
progenitor proliferation and increased the neuronal com-
partment size, whereas in the absence of Asb11 premature
terminal differentiation was induced resulting in a reduced
compartment size. The molecular mechanisms by which
Asb11 sustains progenitor expansion likely involve Notch
activation as we established that Asb11 is a positive regula-
tor of canonical Notch signaling [12,19,20]. However, d-
Asb11 function in embryogenesis and adult organisms has
not been fully explored, and thus, it is possible that d-Asb11
is relevant for compartment definition outside the neuronal
system, prompting more comprehensive analysis of its
in vivo expression. Indeed, Asb11 was well capable of acti-
vating Notch signal transduction outside the neuronal sys-
tem as heterologous expression of this gene activates Notch
reporters in a variety of cell types [19].
In this context, muscle development may constitute an
interesting target for Asb11 action as other ASB family
members have been especially implicated in the regulation
of this compartment [6,19]. ASB2b was first identified in
muscle cells during embryogenesis and in adult tissue, and
was shown to regulate muscle differentiation by targeting
actin filamin B (FLNb) for proteasomal degradation. In-
hibition of ASB2b blocked myoblast fusion and myotube
formation, crucial processes in the later phase of muscle
development [21]. Additionally, ASB15 has emerged as a
regulator of protein synthesis and muscle growth [22],
possibly mediated by the PI3K/Akt signal transduction
pathway [23]. Besides, analysis of Asb11 transcripts showed
that the expression of this gene in muscle tissue has a pan-
vertebrate characteristic, presenting a particularly high ex-
pression in mammalian muscle (mouse and human). Hence,
we decided to characterize the function of d-Asb11 during
myogenesis. Further analysis showed that d-Asb11 ex-
pression is specifically restricted to Pax7 + compartment
and may be important for progenitor maintenance. Down-
regulation of d-Asb11 activity, using a mutated form of
d-Asb11, interfered with myotome formation during em-
bryogenesis and adult muscle regeneration, whereas forced
expression led to expansion of the muscle compartment
both in vitro and in vivo. We conclude that d-Asb11 con-




Embryos were obtained by natural matings, cultured in
embryo medium, and staged according to methods previ-
ously described [24]. Zebrafish were kept at 27.5"C.
Cell culture
C2C12 mouse myoblasts were obtained from the ATCC
and cultured in Dulbecco’s modified Eagle’s medium (Gibco)
with 4.5 g/L glucose and L-glutamine and supplemented
with penicillin (50U/mL), streptomycin (50mg/mL), and
10% fetal calf serum (FCS). Cells were grown in monolay-
ers in a humidified atmosphere containing 5% CO2. The
differentiation medium contained 2% horse serum instead of
10% FCS.
Plasmid construction
Plasmids, containing asb11 and related sequences, were
constructed as described previously [12]. A partial cDNA
fragment of asb11 in pBluescript was used as a template to
generate a riboprobe for in situ hybridizations.
mRNA synthesis, mRNA, and cDNA microinjections
Capped mRNAs were synthesized using the mMESSAGE
mMACHINE kit (Ambion). mRNAs were injected into 1-cell-
stage embryos or in 1 cell of the 2-cell stage blastomere.
cDNA and mRNA were injected by using a microinjector
(World Precision Instruments). About 300pg of Asb11
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mRNA or 10pg of cDNA was used unless otherwise indi-
cated. Total volume of the injection was set at 1 nL.
RNA isolation and quantitative reverse
transcriptase–polymerase chain reaction
Total RNA extraction and purification was performed
by using standard Trizol and isopropanol precipitation.
cDNA synthesis was performed using hexamer primers
and MLV reverse transcriptase. Transcript levels were
quantified by real-time polymerase chain reaction (PCR)
using ABsolute QPCR SYBR Green Fluorescein Mix
(Westburg) on an iCycler iQ Real-Time PCR detection sys-
tem (Bio-Rad). Results are expressed as a relative ratio to the
housekeeping gene actin.
Primers
Zebrafish: asb11-F: CTGCAAAGAGAGGTCACACG and
asb11-R: TCCTTTTTGTCCCAGTGAGC. Mouse: Asb11-F:
GTCAGAAGGCCTGGACCAT and Asb11-R: CTCATGGAG
TGGGGATCG. Asb9-F: TCCTCTTCATGATGCTGCAA and
Asb9-R: CACGTGATCTGCTGTGATGA.
In situ hybridization
mRNA WISH was carried out as previously described
[25]. Embryos were fixed in 4% paraformaldehyde (PFA)
overnight at 4"C and digoxigenin-tagged probes to myoD,
muscle creatine kinase (mck), and myogenin were made with
Roche labeling mix [26]. Images were obtained using a Zeiss
Axioplan Stereomicroscope (Oberkochen) equipped with a
Leica (Wetslar) digital camera.
Immunolabeling of zebrafish embryos
Embryos were fixed for antibody staining with 4% PFA
and whole mount immunohistochemistry was performed ac-
cording to Du et al. [27], using primary antibodies Pax7 1:20
(Developmental Studies Hybridoma Bank) and PH3 (Upstate
Biotechnology; #06570) 1:1,000. Appropriate secondary anti-
bodies were used at 1:200. Immunohistochemistry was ana-
lyzed at the level of yolk extension.
Immunolabeling of adult muscle
All stainings were initially performed as monostainings to
assess the problem of bleed-through of the fluors. Subse-
quently, concentrations were titrated to minimize the prob-
lem (ie, if staining in 1 channel was markedly stronger as in
another channel, causing bleed-through antibody, then con-
centrations were adjusted to reduce staining intensity). In
addition, only double stainings were accepted for further
analysis when in the same field clear monostained structures
could also be recognized.
Short-term (7 days) and long-term (2 months) bromo-
deoxyuridine (BrdU) incorporation and labeling was per-
formed by immersing and allowing the zebrafish to swim in
BrdU (150mg/L for 4 h per day) for 7 days. Fish were fixed
at 2 months after the BrdU pulse. Adult muscle tissue was
isolated and frozen in liquid nitrogen, postfixed in 4% PFA,
cryosectioned in 10mm, and dried overnight. Sections were
postfixed in acetone, washed, and kept in 100% methanol
overnight. Sections were permeabilized with 0.2% Triton X-
100 and quenched with 100mM glycine-NaOH (pH 10).
Sections were washed in PBS-Tween-20 (PBS-T) and incu-
bated in 2N hydrochloric acid. To restore the pH, sections
were washed in 0.1M sodium borate. After washing in PBS-
T, sections were blocked [2% goat serum, 1% bovine serum
albumin (BSA), and 1% dimethyl sulfoxide (DMSO) in PBS-
T] at room temperature for 1 h. BrdU antibody (Abcam;
Ab6326) was incubated 1:200 in block overnight at 4"C. After
washing in PBS-T, sections were blocked again for 1 h and
anti-rat conjugated secondary antibody (Cy2/Jackson Im-
munoresearch; 1:200) was incubated for 2 h at room tem-
perature (RT). After washing, sections were blocked (20%
goat serum and 0.1% BSA in PBS) for 1 h. Asb11 antibody
[12] was pre-incubated in fish powder and subsequently
incubated in block (10% goat serum and 0.1% BSA) over-
night at 4"C. After washing in PBS-T, sections were blocked
for 1 h and incubated in anti-rabbit secondary antibody
(Cy3/Jackson Immunoresearch) for 2 h at RT. After washing,
sections were blocked (10% goat serum, 0.1% BSA, and 1%
DMSO in PBST) for 1 h at RT and incubated in Pax7 antibody
(Developmental Studies Hybridoma Bank) 1:20 in block
overnight at 4"C. After washing in PBS-T, sections were
blocked and incubated in anti-mouse secondary antibody
(Rhodamine Red-X/Jakson Immunoresearch) for 2 h at RT.
After immunolabeling, sections were counterstained in DAPI
(Sigma) and analyzed by confocal microscopy as described
earlier [28].
Tissue histology
For cryosections, adult muscle tissues were embedded in
Jung Tissue Freezing Medium, and sectioned at 10 mm. For
plastic sections, adult muscle tissues were dehydrated and
rehydrated in an ethanol gradient. Adult muscle tissues were
embedded in Technovit 8100 (Kulzer) and sectioned at 7mm.
Sections were then counterstained with Mayer’s hematoxylin
and eosin.
Zebrafish cell lysate for immunoblotting
Embryos were dechorionated at the appropriate stage and
subsequently transferred to cell lysis buffer [50mM HEPES
(pH 7.5), 150mM NaCl, 1.5mM MgCl2, 1mM EGTA, 10%
glycerol, and 1% Triton-X 100] at 4"C (2 mL/embryo), and
subsequently lysed by pippeting up and down and stored
at - 20"C. Before loading, 2 · loading buffer was added and
the sample was boiled for 5min. A total of 7 embryos was
loaded.
Immunoblotting
Cell lysates were sonicated and then centrifuged at 1,200 g
for 10min at 4"C. The pellet was discarded and the protein
concentration was measured with the BCA protein assay kit
(Pierce chemical Co.). Lysates were diluted 1:2 in protein
sample buffer [125mM Tris/HCl (pH 6.8), 4% sodium do-
decyl sulfate (SDS), 2% b-mercaptoethanol, 20% glycerol,
and 1mg bromophenol blue] and incubated at 95"C for
5min. Twenty-five micrograms of protein per lane was loa-
ded onto SDS–polyacrylamide gel electrophoresis and sub-
sequently transferred onto PVDF membrane (Millipore)
as described earlier [29]. The blots were blocked with 2%
ASB11 AND MUSCLE COMPARTMENT SIZE 3
low-fat milk in Tris-buffered saline supplemented with 0.1%
Tween-20 (TBST) for 1 h at room temperature and washed in
TBST before overnight incubation at 4"C with primary anti-
body in 2% low-fat milk in TBST. Blots were then washed
with TBST and incubated for 1 h at room temperature in
1:1,000 horse radish peroxidase conjugated secondary anti-
body in 2% low-fat milk in TBST. After a final wash with
TBST, blots were incubated for 5min in Lumilite plus
(Boehringer-Mannheim) and then chemiluminescence de-
tected using a Fuji LAS3000 illuminator (Fuji Film Medical
Systems).
Luciferase reporter assay
C2C12 cells were transiently cotransfected with an MCK
promoter-driven luciferase construct and one of the follow-
ing constructs: myc-tagged Asb11 (MT-Asb11), HA-tagged
SOCS box deficient Asb11 (HA-Asb11DSOCS), myc-tagged
Asb9 (MT-Asb9), or myc-tag empty vector (MT). To correct
for transfection efficiency or dilution effects, cells were
transfected as explained previously but reporter vector was
replaced with a cytomegalovirus (CMV) promoter-driven
Renilla luciferase (Promega). Lipofectamine Plus (Invitrogen)
method was used according to manufacturer’s instruction.
After 48, 72, or 96 h of incubation in differentiation medium,
cells were lysed with passive lysis buffer as provided
by Promega and luciferase activity was assayed according to
the Dual-Glo-Luciferase Assay System (Promega) proto-
col on a Lumat Berthold LB 9501 Luminometer (Berthold
Technologies).
Imaging and quantifications
Fluorescent labeling was imaged using a Leica TCS SPE
confocal microscope. BrdU+ , Pax7 + , and Asb11 + cells in the
adult muscle tissue were counted at comparable positions at
the dorsal part of the myotome. For statistical analysis, het-
eroscedastic 2-tailed Student’s t-test was performed using
Microsoft Excel.
Results
Specific expression of Asb11 in the Pax7 + muscle
satellite cell
In an effort to determine possible extra-neuronal func-
tions for Asb11, we explored the specific distribution of
d-asb11 transcripts in adult zebrafish tissues by reverse
transcription–PCR. d-asb11 cDNA from total mRNA ex-
tracted from muscle, heart, eye, intestine, gills, testis, pan-
creas, and brain was amplified. b-Actin was used as a
control. d-asb11 was expressed in all the tissues we explored
(Fig. 1A), indicating functionality outside the nervous sys-
tem, and possibly in muscle. This notion is reinforced by
experiments attempting a pan-vertebrate comparison of
Asb11 expression.
In mammals and birds 2 orthologues of d-asb11 are pres-
ent, Asb9 and Asb11, which are highly homologous, both
sharing*70% sequence similarity to d-asb11. Asb9 and Asb11
lie adjacent to each other on the X-chromosome, suggesting a
sarcopterygiic-specific gene duplication event, not present in
teleosts. We investigated specific-tissue expression of murine
Asb11 and murine Asb9 and observed particularly prominent
Asb11 expression in skeletal and cardiac muscles and less,
but significant, expression in brain (Fig. 1B), whereas Asb9
was strongly expressed in testis and kidney (Fig. 1C). This is
in agreement with the earlier established function of asb11 in
regulating compartment size in the central nervous system of
zebrafish embryos, but the expression of Asb9 in testis and
kidney shows that high expression of asb11 orthologues in
distinct mammalian tissues is a phenomenon observed in
evolutionary highly divergent vertebrates and calls for an
investigation to the role for d-Asb11 in zebrafish compart-
ment expansion in these tissues.
To analyze the endogenous expression of d-Asb11 during
embryogenesis, we isolated total cell lysates of zebrafish
embryos at 12, 14, 16, and 24 hours postfertilization (hpf )
and compared protein levels of d-Asb11 and MCK, a marker
for terminal muscle differentiation whose onset of expression
coincides with the end of progenitor expansion [30,31]. In-
deed, as expected, expression of MCK protein increases
throughout somitogenesis (Fig. 1D). Consistently with a role
of d-asb11 during progenitor expansion in muscle develop-
ment, the expression of Asb11 is high during early myo-
genesis and diminishes when the final stages in muscle
differentiation ensue, being approximately complementary
to the expression of MCK.
Next, we analyzed the histological localization of d-asb11
and its relationship with progenitor cells. Cross sections of
skeletal muscle tissue of zebrafish were costained with an
antibody specific for d-Asb11 and the well-established
muscle satellite marker Pax7 [32,33]. Asb11 staining dis-
played a distinct expression pattern on the sarcolemma
where it colocalizes with a portion of the Pax7+ compart-
ment (Fig. 1E). To confirm that these Pax7+/Asb11+ cells
represent muscle progenitor cells, we tested their long-term
BrdU label retention. The results, presented in Fig. 1E, con-
firmed that this double compartment truly represented
slowly-cycling satellite cells. Thus, the muscle stem cell
compartment in adult muscle is characterized by highly
specific Asb11 expression in this compartment.
Forced expression of asb11 inhibits muscle cell
differentiation and supports progenitor expansion
in the C2C12 model system
Heterologous expression of asb11 has been shown to
support progenitor expansion while simultaneously inhibit-
ing terminal differentiation in the PC12 and N-Tera2 in vitro
model systems for neurogenesis [12]. Expression of Asb11 in
the satellite cell compartment may suggest that Asb11 could
also act in a similar manner in muscle formation. Mouse
C2C12 myoblasts, upon application of differentiation me-
dium, synchronously withdraw from the cell cycle, elongate,
adhere, and finally fuse together to form myotubes exhibit-
ing most mechanobiochemical adaptations associated with
fully differentiated muscle [34] (Fig. 2A). Thus, this system
represents a valuable model to study the effect of Asb11 on
muscle cell differentiation.
Confirmation of the inhibitory effects of Asb11 on muscle
cell differentiation was obtained from experiments in
which C2C12 cells, upon differentiation medium, were
transfected with different constructs in combination with
MCK promoter-driven luciferase or a construct containing a
CMV promoter-driven luciferase. Vectors containing either
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the HA-tag (HA) or a SOCS-box deficient version of asb11
(HA-Asb11DSOCS) were used as controls.
Differentiation induction of luciferase-mediated MCK
promoter was significantly inhibited in the presence of MT-
Asb11 or MT-Asb9 (orthologue of zebrafish asb11 in the hu-
man genome, together with Asb11), while no significant ef-
fect was shown by coexpression with the Asb11 lacking the
SOCS box domain (Fig. 2B). Subsequently, we tested the
effect of MT-Asb11 as well as MT-h-ASB9 on the expression
of the early myogenic marker myogenin (MyoG) [35] and the
FIG. 1. Distribution ofAsb11 expression in different tissues and colocalizationwith Pax7+ satellite cells. (A)RT–polymerase chain
reaction analysis of zebrafish d-Asb11 (asb11) in mRNA samples isolated frommuscle, heart, eye, intestine, gill, testis, pancreas, and
brain of adult fish. Zebrafish b-actinwas used as template control. (B, C)Various types of tissue from adult mice were analyzed for
mRNA expression of murine Asb9 (Asb9) (B) and Asb11 (Asb11) (C). Results were normalized against b-actin expression. Asb9 is
showing thehighest expression inkidney, heart, andmuscle.Asb11 shows thehighest expression inmuscle, heart, kidney, andbrain.
The bars indicate the standard error of the mean and were calculated from the results of 3 individual experiments. (D)Analysis of
protein levels of Asb11 and muscle creatine kinase (MCK), a marker of muscle terminal differentiation, in different stages during
embryogenesis. Hsp70 expression is used as input control. Expression of MCK and Asb11 showed inverse correlation during
zebrafish embryogenesis. The images shown are representative for 3 independent experiments. (E) Adult zebrafish muscle was
immunostainedwithbromodeoxyuridine (BrdU),Pax7, andd-Asb11antibodies.Toppanels showarepresentative stainingof sagittal
sections and bottom panels show a representative of transverse sections. d-Asb11 revealed a distinct expression pattern on the
sarcolemmawhere it colocalizeswith Pax7+ cells. The capacity of Pax7+/Asb11+ cells for long-termBrdU incorporationwas tested
and confirmed that this double-positive compartment truly represents slow-cycling satellite cells. 4¢,6-diamidino-2-phenylindole
staining was included to determine cell locations (white bars are 10mm). Color images available online at www.liebertpub.com/scd
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terminal myocyte marker myosin heavy chain (MHC) [36]
(Fig. 2C). As expected, both genes were substantially in-
duced under differentiation conditions in control cells. After
verification that the different Asb constructs were sufficiently
expressed (Fig. 2C) we investigated the influence of such
heterologous expression on in vitro muscle differentiation.
Importantly, when cells were transfected with expressing
MT-asb11 or MT-h-ASB9 constructs, differentiation no longer
induced MHC expression (Fig. 2C). However, induction of
MyoG was unaffected by expression of either MT-Asb11 or
MT-ASB9. Together, these observations showed that forced
expression of Asb11 prevents terminal myocyte differentia-
tion but not myoblast differentiation of muscle precursors, at
least in the C2C12 model system, consistent with a possible
role of d-asb11 in maintaining progenitor proliferation in
muscle.
Forced expression of Asb11 in vivo deregulates
differentiation in the presumptive myotome
and causes hyperplastic myotome formation
A prediction from the proposed role of d-asb11 as a factor
inhibiting differentiation and maintaining proliferation in the
Pax7 + muscle stem cell compartment would be that forced
expression of asb11 is associated with impaired differentia-
tion in zebrafish muscle. Thus, we injected MT-asb11 mRNA
into 2-cell stage blastomeres, and investigated the expression
pattern of myoD, a bHLH transcription factor that is ex-
pressed in adaxial cells and in the posterior region of each
developing somite [31,37], by using WISH. An anti-Myc tag
antibody was used to confirm expression of injected mRNA
and to identify the half of the embryo derived from the in-
jected blastomere. Compared with wild-type expression
FIG. 2. Heterologous expression of d-Asb11 or h-Asb9 prevents terminal differentiation in the C2C12 model system of
skeletal muscle differentiation. (A) Schematic illustration of the various stages of skeletal muscle differentiation as observed in
the C2C12 model system and the associated expression of markers of muscle differentiation. (B) Following 96 h of exposure to
differentiation medium, terminal differentiation of skeletal muscle, as assayed by luciferase activity driven by the MCK
promoter, was inhibited by heterologous expression of either asb11 or h-Asb9. Transfection of a vector expressing only myc-
tag (MT) or a HA-tag suppressor of cytokine signaling (SOCS) box deficient d-Asb11 (HA-d-Asb11DSOCS) showed no
inhibitory effects. As a control for transfection efficiency, cytomegalovirus (CMV) promoter activity was used. Error bars
show standard error of the mean (SEM) of 3 experiments. Statistical testing was done by comparing experimental groups to
MT-only-transfected cells using a heteroscedastic paired Student’s t-test. (C) C2C12 cells were transfected with a vector
containing only the MT, MT-asb11, HA-asb11DSOCS, or MT-hAsb9 and allowed to differentiate for 72 h in the appropriate
medium. Positive expression of the constructs was assessed and is shown on the left side of the panel. Effects of these
transgenes on the expression of myogenin (MyoG; a myoblast marker) and myosin heavy chain (MHC; a marker of terminal
muscle cell differentiation) were tested either in undifferentiated cells (left) or after 72 h under differentiation medium
treatment (right). A representative image from 3 independent experiments is shown. **P < 0.01.
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(Fig. 3A), forced expression of MT-asb11 resulted in loss of
somitic myoD expression accompanied by variably reduced
or absent expression in adaxial cells at 13–14 hpf in > 80% of
the injected embryos (n = 82) (Fig. 3B–D). Further, the ex-
pression pattern ofMT-d-Asb11 in the embryo coincided with
exclusion of myoD expression (Fig. 3E–F). Additionally,
when expressed in the whole embryo, Asb11 affected myoD
in the entire myotome, showing a bended and/or displaced
expression pattern at later stages (16 hpf ) (Fig. 3G–I). Hence,
forced expression of d-Asb11 delays acquisition of myoD
FIG. 3. Forced expression of asb11mRNA interfereswithmuscle differentiation in vivo. (A–D)Zebrafish embryoswere injected
at the 2-cell stage in 1 of the 2 blastomeres (marked with asterisk) with encoding full-length MT-d-asb11 mRNA (300pg). The
numbers indicate the percentages of injected embryos displaying the particular phenotype (total n= 82). Panel A shows an
uninjectedwild-type embryo. (E, F) Immunolabeling ofMT-Asb11 overlaywithmyoD in situ hybridization. (G–O) Embryoswere
injected at 1-cell stage with Asb11 mRNA and fixed at 16 hours postfertilization (hpf ). Whole mount in situ hybridization was
performed using (G–I)myoD, ( J–L)mck, and (M–O)myoG riboprobe. Expressionwas compared between uninjected (G, J,M) and
injected embryos (H, I, K, L, N, O). (P–S)Abnormal axial muscle formation at 36hpf in response to d-asb11mRNA injections. Fast
and slow muscle fibers were stained by immunolabeling as described earlier [33]. (T) Confirmation of d-asb11-forced expression
effects on mck at the protein levels. Zygotes were injected MT-asb11 mRNA, MT only, or MT-asb11DSOCS-injected embryos,
serving as controls. Total cell lysates were isolated at 16hpf. The protein was analyzed using an anti-Mck antibody. Anti-MT
antibody was used to verify induced expression of asb11 variants, and as a loading control an anti-Hsp70 antibody was used. A
representative image from 3 independent experiments is shown. Color images available online at www.liebertpub.com/scd
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positivity in the presumptive axial myotome and deregulates
important aspects of differentiation during zebrafish em-
bryogenesis. As judged by mck expression—a marker for
advanced muscle cell differentiation—d-asb11 misexpression
inhibited terminal muscle differentiation (Fig. 3J–L), whereas
myoG expression—a more early marker of muscle differen-
tiation—was only marginally affected by such asb11 mis-
expression (Fig. 3O).
In an effort to confirm these effects at the protein level,
zygotes were injected with MT- asb11 and MT-Asb11DC
mRNA. Uninjected embryos and embryos injected with MT
only served as controls. Total cell lysates were isolated at
16 hpf and analyzed using an anti-MCK antibody, while an
anti-MT antibody was used to verify induced asb11 variants
(Fig. 3T). Indeed, forced expression of asb11 caused reduction
of Mck, in agreement with its inhibitory function of cell dif-
ferentiation.
Finally, to analyze the effects of forced d-Asb11 expression
in slow and fast muscle fiber formation, we injected MT-
Asb11 mRNA in zygotes that were then immunostained at
36 hpf. At this time point, aberrant expression of d-Asb11
caused gross abnormalities in both slow and fast muscles
(Fig. 3P–S), accompanied by disruption of normal muscle
architecture. Together, these results indicate an important
role for d-asb11 in muscle progenitor expansion.
Earlier we have shown that in the presumptive neuronal
system forced expression of d-Asb11 increases proliferation
[12] concomitant with the delay in the acquisition of terminal
differentiation markers. The in vitro experiments suggest that
d-Asb11 can also maintain proliferation in the developing
myotome. Thus, we assume that the misexpression of d-Asb11
will coincide with increased proliferation of the presumptive
musculature. To analyze this possibility further, we injected
different concentrations of d-Asb11 mRNA in zygotes, using
GFP mRNA as a control. Misexpression of d-Asb11 mRNA in
3 independent experiments, each consisting of at least 60 asb-a
mRNA-injected embryos, resulted among others in cyclopia,
notochord defects, and tail phenotypes (23%), including no tail
(ntl)–like phenotype and in a loss of 1 of the 2 pectoral fins
(4%), whereas control mRNA never induced these effects,
even when the control RNA was injected at twice the con-
centration of d-Asb11 mRNA. The notochord and tail pheno-
types and the cyclopia are especially evident at higher d-Asb11
mRNA concentrations (Fig. 4A), which finally may cause se-
vere dysmorphogenesis but also the myotome appears sig-
nificantly enlarged (Fig. 4A). Morphometric analysis confirms
this notion (Fig. 4B). Thus, it appears that the block in muscle
differentiation provoked by d-Asb11 overexpression coincides
with compartment expansion.
Fish homozygous for a hypomorphic Asb11
mutation are impaired in muscle progenitor
expansion and myotome formation
The expression of d-Asb11 in the muscle progenitor cell
compartment and the inappropriate expansion of the myo-
tome following its misexpression suggest that d-Asb11 is
important for progenitor expansion. Thus, we decided to
investigate the effect of moderate d-Asb11 deficiency during
muscle development. To this end, we employed a mutant d-
asb11 zebrafish germline (d-asb11cul) that lacks the cullin box,
a SOCS box subdomain, resulting in a hypomorphic allele.
We recently described the isolation of d-asb11cul mutants in
detail and demonstrated that these are defective in Notch
signaling and have impaired cell fate specification within the
neurogenic regions of the embryos [20]. We did not analyze
effects on muscle development, however. The d-asb11cul
mutants survive until adulthood; however, they present a
subtle shorter trunk and less well-defined somites. Interest-
ingly, when the developing myotome was analyzed for the
number of proliferating muscle progenitor cells, as defined
by phospho-histone 3 (pH3) and Pax7 double staining, this
number was significantly reduced in the d-asb11 mutants
(Fig. 5A). Further, as judged by the expression of mck, muscle
terminal differentiation in d-asb11cul embryos is temporally
enhanced (Fig. 5B), whereas the cell proliferation in the
myotome of these mutants is substantially reduced (Fig. 5C–
E). Thus, we conclude that d-asb11 is required for maintain-
ing myogenic proliferation in the stem cell compartment
during embryogenesis.
Expression of d-Asb11 in proliferating satellite cells
is important for adult regenerative myogenesis
To determine whether regenerative myogenesis like pri-
mary embryogenesis is regulated by Asb11, we induced
mechanical injury with a 30G needle on the adult zebrafish
body musculature, dorsal to the anus, and investigated
the number of BrdU + , Pax7 + , and Asb11 + cells in lesion-
induced versus uninjured wild-type zebrafish at 7 days
postinjury. Although this procedure does not produce sig-
nificant changes in the number of BrdU + or Pax7+ cells,
the double-positive d-Asb11 +/Pax7 + compartment sub-
stantially increases in size following muscle injury, indicat-
ing that d-asb11 may be involved in response to trauma in
this tissue (Fig. 6A). Subsequently, we compared the prolif-
eration between injured d-asb11cul and wild-type zebrafish.
Injured d-Asb11cul mutants showed a significant diminished
numbers of BrdU+ cells (Fig. 6B), suggesting that regenera-
tive proliferation is dependent on functional Asb11.
Next, we performed a muscle regeneration comparative
analysis using injured tissues of wild-type, d-Asb11cul, and
axin1/apc1 mutants. axin1/apc1 double heterozygous mutants
were used as positive controls as Wnt signaling is shown to
positively regulate satellite cell proliferation on adult muscle
fibers during wound-healing response in CD34 + cells [38] as
well as cultured myofibers [39].
At day 0, muscle fiber morphology was comparable in
wild-type, axin1/apc1, and d-Asb11cul zebrafish lines (Fig.
6C, G, K). At day 1 postinjury, there was a marked cellular
invasion, and evident degeneration and necrosis of mature
fibers of all tissues (Fig. 6D, H, L). At day 5 postinjury,
axin1/apc1 mutants showed remarkable recovery and nu-
merous small-diameter regenerating muscle fibers were
observed (Fig. 6I), whereas wild type showed a slight re-
covery (Fig. 6E) and in d-Asb11cul the muscle fibers were
still necrotic (Fig. 6M). At day 10 postinjury, axin1/apc1
showed a clear recovery and regeneration of the muscle
fibers (Fig. 5J), while the aspect of wild-type fish appeared
only moderately worse (Fig. 6F). In d-Asb11cul, however,
little improvement could be noted with small regenerating
fibers emerging (Fig. 6N). Altogether these results establish
a crucial role of Asb11 in both embryonic and adult re-
generative myogenesis.
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FIG. 5. Fish harboring a hypomorphic asb11 allele show reduced size of the pax7+ progenitor compartment and precocious
terminal differentiation. Isolation of the hypomorphic asb11 allele-containing asb11cul fish has been described before [20]. (A)
At 24 hpf, the size of the expanding muscle progenitor compartment was determined by double labeling with anti-PH3
antibody (a marker for proliferating cells) and an anti-Pax7 antibody. Cells were counted at equivalent positions in the
developing dorsal myotome. The asb11cul embryos have significantly lower numbers of proliferating muscle progenitor cells
(n = 3). The bars show standard deviation, the asterisk indicates P < 0.05 (using a heteroscedastic paired Student’s t-test). (B)
Wild-type and mutant embryos were fixed at 16 hpf and tested for advanced muscle differentiation using mck riboprobes.
(C–E) Proliferation in the presumptive myotome of wild-type (C) and d-asb11cul (D) embryos was visualized by anti-pH3
staining at 48 hpf, representative image (n = 3). Quantification of total proliferation in zebrafish embryos using the number of
PH3-positive cells as a surrogate measure (E). The results represent the average of 8 embryos. The bars depict SEM; *P < 0.05
(using a heteroscedastic Student’s t-test). Color images available online at www.liebertpub.com/scd
FIG. 4. Forced expression of asb11 mRNA increases muscle compartment size. (A) Zebrafish zygotes were injected at the 2-
cell stage with encoding full-length MT-d-asb11 mRNA at different concentrations or 200 pg of GFP-encoding mRNA as a
control. Injection of increasing amounts of d-Asb11 mRNA (50, 100, 150, and 200 pg) in zygotes causes CNS and especially
brain hypertrophy, which was described earlier at 48 h [12], but also the muscle compartment appears enlarged. Ob, olfactory
bulb; Te, telencephalon; Cb, cerebellum; Am, adaxial myotomes; Ey, Eye; Yo, yolk sac; CNS, central nervous system. Bar
indicates 100mm. (B)Morphometric analysis of the adaxial myotome hemicircumference at equivalent position in the embryo is




The determinants of the size of the muscle cell compart-
ment remain poorly understood. During embryogenesis a
group of Pax7 + stem cells arises and proliferates until the
final compartment size is reached. In most precursor cells, a
genomic program, responsible for terminal differentiation, is
started resulting in functional muscle fiber, whereas a small
subpopulation remains Pax7+ cells forming the satellite cell
population from which regenerative myogenesis can start in
response to injury. Our data presented here show that d-
Asb11 is essential for maintaining muscle stem cell prolifer-
ation during zebrafish embryogenesis and is required for
regenerative responses during injury as well. Importantly,
we demonstrated that d-Asb11 is expressed beneath the ba-
sal lamina of adult zebrafish muscle fiber, and colocalized
with a well-accepted muscle satellite cell specific marker
Pax7. This, together with the coexpression of d-Asb11 with
FIG. 6. The hypomorphic asb11cul allele is associated with impaired regenerative responses following mechanical injury.
Mechanical injury was induced using a needle to inflict trauma on the dorsal flank of the muscle in adult zebrafish. (A)
Zebrafish were fixed and frozen 7 days postinjury. Adult muscle tissues were cryosectioned and immunostained with BrdU,
Pax7, and d-Asb11. Quantification of the percentage of positively stained cells was performed. Error bars indicate the
standard deviation calculated from data obtained from 8 different embryos. (B) Wild-type, axin - /apc - , and d-Asb11cul
zebrafish were fixed and frozen 7 days postinjury. Adult muscle tissues were cryosectioned and immunostaining with BrdU
antibody was performed. (C–N) Zebrafish were fixed at (C, G, K) 0, (D, H, L) 1, (E, I, M) 5, and (F, J, N) 10 days postinjury.
Evans blue dye was used as a marker to identify the area of injury. The adult musculature was sectioned and counterstained
with haematoxylin-eosin (HE). Color images available online at www.liebertpub.com/scd
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label-retaining BrdU slow-cycling cells suggested that the d-
Asb11-positive cells are the muscle satellite cells themselves.
Interestingly, there are significantly less Asb11 + cells com-
pared with Pax7 + cells in the adult muscle fibers. It is
tempting to speculate that the d-Asb11 cells are the primary
stem cells, and thus, are activated and induced to proliferate
in response to muscle damage/injury.
The d-Asb11 gene has high homology to both mammalian
Asb9 and Asb11; however, no obvious asb9 homologue is
present in fish. As mammalian Asb9 and Asb11 lie adjacent
on the same chromosome (X), it seems to represent the result
of an evolutionary relatively recent genetic duplication
event. In silico analysis revealed that 46.6% of the ancestral
chordate genes appear in duplicate in one or more of the
vertebrate lineages, with 34.5% having at least 1 duplication
before the divergence of fish from tetrapods and 23.5%
having at least 1 duplication afterward [40]. This suggests
that zebrafish asb11 functions similarly to both mammalian
Asb9 and Asb11, as it seems that d-Asb11, in zebrafish, bears
a more varied number of functions, while in mammals the
function of ASB proteins appears to be more specific. This
hypothesis is supported by our results where zebrafish asb11
transcripts were present in all tissues analyzed, whereas mice
showed more tissue-specific expression for both Asb9 (testis
and kidney) and Asb11 (muscle and heart) transcripts, al-
though there is no information of the function of these genes
in male germ cell compartment, urogenital system, or muscle
development. However, ASB1 [41] and ASB17 [42], which
are also highly expressed in mice testis, have been implicated
in mammalian spermatogenesis. Moreover, human and
murine Asb9 were reported to interact with the creatine ki-
nase isoforms, brain creatine kinase [14] and ubiquitous
mitochondrial creatine kinase [43], targeting them to pro-
teosomal degradation. In agreement with the notion that
zebrafish use Asb proteins in multiple compartments,
whereas in mammals ASB proteins function in specific
compartments, zebrafish present a smaller number of Asb
proteins compared to humans and mice. Clearly, more in-
depth analysis of expression and function of different Asb
proteins in different tissues is required; however, it is
tempting to speculate on a function of d-Asb11 in zebrafish
spermatogenesis and kidney development.
Earlier, we have demonstrated that d-Asb11 maintains the
neuronal progenitor compartment, implying a critical role in
the ectodermal compartment size. In zebrafish, this function
does not seem to be restricted to this germ layer, as we now
show that it is important for mesodermal lineage as well and
hence d-Asb11 appears a regulator of vertebrate compart-
ment size of more general importance. The effects of d-Asb11
on embryonic myogenesis are remarkably similar to its ef-
fects on embryonic neural precursors [12], suggesting that d-
Asb11 functions in a similar way in regulating both the
neuroectodermal and mesodermal cell fates. Whether d-
Asb11 is important for compartment size in the endodermal
lineage, however, is questionable. Interestingly, ASB9 ex-
pression has recently been linked to the maintenance of cell
proliferation in colorectal cancer [44]. In this context it is
interesting to note that we observe higher expression of the
CysLT1 receptor in Asb9-expressing colon cancer cell lines
(unpublished observations) and that expression of this re-
ceptor has been linked to compartment expansion in colon
cancer [45]. Thus, further investigations on how endodermal
progenitor expansion is regulated and whether they involve
ASB-like proteins should be warranted.
Recently we showed that the functions of Asb11 in neu-
rogenesis are mediated by its potential to enable Notch sig-
naling activity [19]. Canonical Delta-Notch signaling plays a
key role in satellite cell activation and muscle regeneration.
There is a temporal switch between Notch and Wnt signal-
ing, whereby Notch signaling has to be downregulated for
myogenesis to proceed [46]. Consistently, our data showed
that asb11 expression in muscle satellite cells is required to
maintain the muscle precursor pool and efficient muscle re-
generation. It is important to note, that although slower,
muscle regeneration is still evident in d-asb11cul zebrafish.
In conclusion, based on the evolutionary conservation of
asb11 with murine Asb9 and Asb11, it is tempting to hy-
pothesize that the phenotypes we observed in the asb11
mutants could be linked to human muscular diseases,
prompting an investigation into the role of Asb11 in muscle
pathology.
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